Cetera Investment Advisers Abiomed Inc Transaction History

Cetera Investment Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$242.49 - $301.46 $19,399 - $24,116	-80 Reduced 1.36%	5,809 $1.43 Million
Q2 2022 Aug 11, 2022	SELL	$224.73 - $338.64 $131,691 - $198,443	-586 Reduced 9.05%	5,889 $1.46 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $1.26 Million - $1.67 Million	4,553 Added 236.89%	6,475 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $30,363 - $37,506	101 Added 5.55%	1,922 $690,000
Q3 2021 Nov 16, 2021	BUY	$310.19 - $376.2 $229,540 - $278,388	740 Added 68.46%	1,821 $593,000
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $99,567 - $133,093	379 Added 53.99%	1,081 $337,000
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $106,934 - $132,818	-374 Reduced 34.76%	702 $224,000
Q4 2020 Feb 17, 2021	BUY	$251.88 - $324.2 $271,022 - $348,839	1,076 New	1,076 $349,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.